Activation of human lung mast cells by monomeric immunoglobulin E

The mechanism of chronic mast cell activation in asthma is unclear. Monomeric immunoglobulin (Ig)E in the absence of allergen induces mediator release from rodent mast cells, indicating a possible role for IgE in the continued activation of mast cells within the asthmatic bronchial mucosa. In this study it was investigated whether monomeric IgE induces Ca2+ influx and mediator release from human lung mast cells (HLMC). Purified HLMC were cultured for 4 weeks and then exposed to monomeric human myeloma IgE. Ratiometric Ca2+ imaging was performed on single fura-2-loaded cells. Histamine release was measured by radioenzymatic assay; leukotriene C4 (LTC4) and interleukin (IL)-8 were measured by ELISA. At concentrations experienced in vivo, monomeric IgE induced dose-dependent histamine release, LTC4 production and IL-8 synthesis. This was associated with a rise in cytosolic free Ca2+. Enhanced histamine release was still evident 1 week after initial exposure to IgE suggesting that continued exposure maintains enhanced secretion. Monomeric immunoglobulin E alone activates cultured human lung mast cells initiating Ca2+ influx, degranulation, arachidonic acid metabolism and cytokine synthesis. These findings support the hypothesis that immunoglobulin E loading of mast cells within the asthmatic airway contributes to the disordered airway physiology of this disease.

[1]  P. Berger,et al.  The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells. , 2004, The Journal of allergy and clinical immunology.

[2]  R. Olivenstein,et al.  The expression of stem cell factor and c‐kit receptor in human asthmatic airways , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  S. Bolsover,et al.  Monomeric IgE Stimulates NFAT Translocation Into the Nucleus, a Rise in Cytosol Ca2+, Degranulation, and Membrane Ruffling in the Cultured Rat Basophilic Leukemia-2H3 Mast Cell Line1 , 2004, The Journal of Immunology.

[4]  H. Matsuda,et al.  IgE alone-induced actin assembly modifies calcium signaling and degranulation in RBL-2H3 mast cells. , 2004, American journal of physiology. Cell physiology.

[5]  P. Bradding,et al.  Inhibition of human mast cell proliferation and survival by tamoxifen in association with ion channel modulation. , 2003, The Journal of allergy and clinical immunology.

[6]  Toshiaki Kawakami,et al.  Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcεRI , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Billah,et al.  Human cord blood-derived mast cells synthesize and release I-309 in response to IgE. , 2003, Life sciences.

[8]  D. Strachan,et al.  Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. , 2003, The New England journal of medicine.

[9]  J. Stankova,et al.  CysLT1 receptor upregulation by TGF-beta and IL-13, but not IL-4, is associated with bronchial smooth muscle cell proliferation in response to LTD4 , 2003 .

[10]  P. Bradding.  The role of the mast cell in asthma: a reassessment , 2003, Current opinion in allergy and clinical immunology.

[11]  T. Casale,et al.  Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. , 2003, The Journal of allergy and clinical immunology.

[12]  J. Stankova,et al.  CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. , 2003, The Journal of allergy and clinical immunology.

[13]  A. James,et al.  Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma , 2002, Thorax.

[14]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[15]  I. Hall,et al.  Tryptase's potent mitogenic effects in human airway smooth muscle cells are via nonproteolytic actions. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[16]  P. Bradding,et al.  Resting and Activation-Dependent Ion Channels in Human Mast Cells1 , 2001, The Journal of Immunology.

[17]  M. Huber,et al.  Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. , 2001, Immunity.

[18]  A. Wardlaw,et al.  Adhesion of Human Lung Mast Cells to Bronchial Epithelium: Evidence for a Novel Carbohydrate-mediated Mechanism , 2022 .

[19]  N. Frossard,et al.  Human bronchial smooth muscle cells in culture produce stem cell factor. , 1999, The European respiratory journal.

[20]  M. Huber,et al.  The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  B. Gibbs,et al.  The effect of recombinant stem cell factor on human skin and lung mast cells and basophil leukocytes , 1997, Inflammation Research.

[22]  B. Helm,et al.  Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen‐specific IgE , 1996, European journal of immunology.

[23]  J. Soriano,et al.  Total serum IgE is associated with asthma independently of specific IgE levels. The Spanish Group of the European Study of Asthma. , 1996, The European respiratory journal.

[24]  S. Durham,et al.  High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. , 1996, American journal of respiratory and critical care medicine.

[25]  S. Holgate,et al.  Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. , 1995, American journal of respiratory and critical care medicine.

[26]  J. Roca,et al.  Relationship between serum IgE and airway responsiveness in adults with asthma. , 1995, The Journal of allergy and clinical immunology.

[27]  T. Yue,et al.  Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. , 1994, Circulation research.

[28]  P. Howarth,et al.  Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. , 1992, The European respiratory journal.

[29]  M. Sears,et al.  Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. , 1991, The New England journal of medicine.

[30]  D. MacGlashan,et al.  Oscillations in free cytosolic calcium during IgE-mediated stimulation distinguish human basophils from human mast cells. , 1991, Journal of immunology.

[31]  S. Wenzel,et al.  Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses. , 1991, The Journal of allergy and clinical immunology.

[32]  F. Martinez,et al.  Association of asthma with serum IgE levels and skin-test reactivity to allergens. , 1989, The New England journal of medicine.

[33]  N. Johnson,et al.  Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. , 1985, British medical journal.